Credit rating
At issue
Rated 26 Apr 2024
Issue-time grade. Ratings can migrate after issuance; live surveillance ratings are coming soon.
Recent trading
Not traded in the last 30 days
No exchange trade for this ISIN in the last 30 days. We only show a traded price when it's recent, since a months-old print isn't a reliable current value.
Where to buy this bond Best offer is the highest yield (lowest effective price) for this exact ISIN among the SEBI-registered online bond platforms (OBPPs) we track. We only show quotes refreshed in the last 24 hours, so a platform that has not been re-checked recently will not appear here. Capera does not sell bonds and does not earn from which platform wins; always confirm on the platform before you buy.
The same security, priced across the online bond platforms we track. Capera does not sell bonds; we show every platform's quote so you can pick the best yield.
No live platform quotes for this ISIN yet.
Ask us to watch it and we'll tell you the moment a platform lists this ISIN, with the live yield, so you never have to keep checking.
2 yr, 11 mo, 19 d to maturity
ISIN
INE0U0U07019Type
NCD
Coupon
11.95%
Payout
Quarterly
Face value
₹48,950
Issue sizeTotal amount raised in this issue (face value × units issued).
₹200 Cr
Listed
Unlisted
TaxInterest is taxed at your income-tax slab rate; no special exemption.
Taxable
Other bonds by MATRIX PHARMACORP PRIVATE LIMITED
Full issuer page →Same issuer, different tenors. Each line is a distinct security; click any to compare it across platforms against the live exchange-traded yield.
| The credit grade assigned at issuance (per rating agency). It is not a live or current rating; subsequent surveillance changes aren't reflected here, so always check the issuer's latest credit rating for an updated view before you invest. | ||||
|---|---|---|---|---|
Matrix PharmacorpINE0U0U07035NCD | AA | 10.00% | 30 Nov 20282.5y left | 14.00% |
Matrix PharmacorpINE0U0U08017NCD | — | 6.00% | 03 Jun 20359.0y left | — |
Secured: backed by a charge over the issuer's assets. Unmarked lines are unsecured.
Click any security to compare it across platforms against the live exchange-traded yield. A blank yield means no recent trade, not no value.
Questions
What is INE0U0U07019 rated?
This security (INE0U0U07019) was rated AA by CRISIL RATINGS LIMITED at issuance (26 Apr 2024). Ratings are per-security, so other instruments from MATRIX PHARMACORP PRIVATE LIMITED can carry different grades. These are issue-time grades; live surveillance ratings are coming soon and can differ.
Where can I buy INE0U0U07019?
We do not yet have live platform quotes for this ISIN. Capera does not sell bonds; when a SEBI-registered online bond platform lists it, its price appears here.
Has INE0U0U07019 traded recently?
Not in the last 30 days. We only surface a traded price when it's recent, since an old last-trade isn't a reliable current price.
Capera
Neutrality
Guarantee
Neutrality guarantee
Prices you can't pay to move.
Capera is editorially independent. We may earn from the platforms and institutions we list, but a commercial arrangement never changes the price or yield we show you.
Neutral by design
We don't sell bonds. We show you everyone's price.
Capera compares the same security across every online bond platform and against the live exchange-traded yield, so you always know where the best deal is.
Explore Capera →